Cargando…
COVID-19 and heart injury: Appropriate methodology is crucial for assessing the emerging evidence
Autores principales: | Kollias, Anastasios, Kyriakoulis, Konstantinos G., Stergiou, George S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267796/ https://www.ncbi.nlm.nih.gov/pubmed/32504623 http://dx.doi.org/10.1016/j.pcad.2020.06.001 |
Ejemplares similares
-
Cardiac injury and prognosis in COVID-19: Methodological considerations and updated meta-analysis
por: Kollias, Anastasios, et al.
Publicado: (2020) -
Anticoagulation therapy in COVID-19: Is there a dose-dependent benefit?
por: Kollias, Anastasios, et al.
Publicado: (2021) -
Clinical hypertension research in patients with atrial fibrillation: At last!
por: Kollias, Anastasios, et al.
Publicado: (2020) -
Statin use and mortality in COVID-19 patients: Updated systematic review and meta-analysis
por: Kollias, Anastasios, et al.
Publicado: (2021) -
Venous thromboembolism in COVID-19: A systematic review and meta-analysis
por: Kollias, Anastasios, et al.
Publicado: (2021)